Cointime

扫码下载App
iOS & Android

Immunovant

company
Funding Round
Post-IPO Equity
Money Raised
$ 200M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion
Roivant Sciences - Yes - Detail